Bills · H.R. 11039 · Text

Introduced in House

Confirmed from the official record

Our copy of the file on govinfo.gov, saved November 19, 2026. Fingerprint (SHA-256): 3c428c7b86f617ef.

H.R. 11039: the bill

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 11039 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                               H. R. 11039

  To expand Federal investment in pediatric cancer research, improve 
 access to clinical trials, support holistic and innovative therapies, 
    reduce the financial burden on families, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 17, 2026

  Mr. Boyle of Pennsylvania introduced the following bill; which was 
 referred to the Committee on Energy and Commerce, and in addition to 
 the Committees on the Budget, and Ways and Means, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
  To expand Federal investment in pediatric cancer research, improve 
 access to clinical trials, support holistic and innovative therapies, 
    reduce the financial burden on families, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ahmad Butler Pediatric Cancer Hope 
for a Cure Act''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Pediatric cancer is the leading cause of disease-
        related death in children in the United States.
            (2) Many children face outdated treatments, long waiting 
        periods, and limited clinical trial access.
            (3) Families often face extraordinary financial hardship 
        related to clinical trial participation.
            (4) Improved investment, coordinated Federal action, and 
        expanded access are necessary to protect and save children 
        battling life-threatening cancers.
            (5) Children from minority, rural, and low-income 
        communities face disproportionate barriers to accessing 
        pediatric cancer care and clinical trials.

SEC. 3. PURPOSES.

    The purposes of this Act are the following:
            (1) To expand federally protected and sustained funding for 
        pediatric cancer research.
            (2) To accelerate scientific discovery with emphasis on the 
        deadliest childhood cancers.
            (3) To ensure nationwide access to pediatric clinical 
        trials regardless of a family's income or location.
            (4) To study and evaluate holistic, integrative, and non-
        traditional therapies.
            (5) To provide families with financial support to 
        participate in clinical trials.
            (6) To establish annual public reporting and accountability 
        of Federal pediatric cancer investments.

SEC. 4. RESEARCH AND PRIORITY AREAS.

    The Secretary of Health and Human Services shall expand and 
intensify efforts to conduct pediatric cancer research, including in 
the following priority areas:
            (1) High-risk and rare pediatric tumors.
            (2) Childhood brain cancers.
            (3) Relapsed and treatment-resistant cancers.
            (4) Survivorship, long-term effects, and quality of life.

SEC. 5. HOLISTIC AND INNOVATIVE THERAPY RESEARCH.

    (a) Study and Evaluation.--The Secretary of Health and Human 
Services, acting through the Director of the National Institutes of 
Health, shall establish a research initiative to study holistic, 
integrative, nutritional, and alternative therapies for pediatric 
cancer that emphasizes rigorous, evidence-based scientific evaluation 
consistent with the research mission of the National Institutes of 
Health.
    (b) Requirements.--Such research shall--
            (1) be evidence-based;
            (2) prioritize safety and efficacy;
            (3) include culturally competent and family-centered 
        approaches; and
            (4) not stop at curing cancer, but also study how to 
        protect survivors from long-term complications and improve 
        their everyday lives after treatment.

SEC. 6. PEDIATRIC CLINICAL TRIAL ACCESS ASSISTANCE GRANTS.

    (a) Establishment.--The Secretary of Health and Human Services (in 
this section referred to as the ``Secretary'') shall award grants to--
            (1) individuals participating in pediatric cancer clinical 
        trials (including the caretakers and family members of such 
        individuals); and
            (2) entities conducting or supporting pediatric cancer 
        clinical trials.
    (b) Applications.--To be eligible to receive a grant under this 
section, an individual or entity described in subsection (a) shall 
submit to the Secretary an application at such time, in such manner, 
and containing such information as the Secretary determines 
appropriate.
    (c) Use of Funds.--
            (1) Individuals.--An individual who receives a grant under 
        this section may use the grant to cover travel, lodging, meals, 
        transportation, childcare, unpaid leave expenses, or other 
        trial-related costs, as the Secretary determines appropriate, 
        for participating in pediatric cancer clinical trials.
            (2) Entities.--An entity that receives a grant under this 
        section may use the grant to expand sites for pediatric cancer 
        clinical trials in medically underserved regions, as the 
        Secretary determines appropriate.

SEC. 7. ANNUAL REPORTS TO CONGRESS.

    (a) Requirement.--The Secretary of Health and Human Services shall 
submit to Congress a report on an annual basis regarding pediatric 
cancer research, including the research conducted pursuant to this Act.
    (b) Contents.--The reports described in subsection (a) shall 
include the following:
            (1) Total funds allocated and expended for pediatric cancer 
        research, including contributions made to the One Lunch 4 Cure 
        National Pediatric Cancer Contribution Fund under section 8.
            (2) Research accomplishments related to pediatric cancer 
        research.
            (3) Progress on high-risk pediatric cancer cures.
            (4) Clinical trial enrollment data and equity gaps with 
        respect to pediatric cancer research.
            (5) Descriptions of the pediatric clinical trial access 
        assistance grants awarded under section 6.
            (6) Recommendations for legislative or administrative 
        action with respect to pediatric cancer research.

SEC. 8. ONE LUNCH 4 CURE NATIONAL PEDIATRIC CANCER CONTRIBUTION FUND.

    (a) Establishment.--The Secretary of the Treasury shall establish a 
fund, to be known as the One Lunch 4 Cure National Pediatric Cancer 
Contribution Fund (in this section referred to as the ``Fund''). Each 
contribution made under this section shall be appropriated to the Fund 
on the date such contribution is made and shall remain available until 
expended.
    (b) Methods of Contributions.--Contributions to the Fund may be 
made through--
            (1) one-time voluntary donations representing the cost of 
        one lunch;
            (2) recurring voluntary donations representing the cost of 
        one lunch per week or one lunch per month;
            (3) voluntary payroll deductions for Federal civilian 
        employees and members of the Armed Forces;
            (4) designations on individual Federal income tax returns 
        as provided in subsection (f);
            (5) employer-matching programs; and
            (6) any other method determined appropriate by the 
        Secretary of the Treasury.
    (c) Sources of Contributions.--Any individual or entity may make a 
contribution to the Fund, including--
            (1) a pediatric cancer nonprofit organization;
            (2) a charitable foundation;
            (3) a children's hospital;
            (4) a research institution; and
            (5) a philanthropic partner organization.
    (d) Use of Funds.--The Secretary of Health and Human Services shall 
use amounts in the Fund for the following purposes:
            (1) The pediatric cancer research described in sections 4 
        and 5.
            (2) The pediatric clinical trial access assistance grants 
        described in section 6.
            (3) Equity initiatives to expand access for underserved 
        communities with respect to pediatric cancer research and 
        treatment.
            (4) Support for military families affected by pediatric 
        cancer.
    (e) Oversight and Transparency.--
            (1) Annual gao audit.--The Comptroller General of the 
        United States shall--
                    (A) conduct an annual audit of contributions 
                received and distributed under this section; and
                    (B) submit to Congress a report describing the 
                results of each such audit.
            (2) Prohibition on use for administrative expenses.--
        Amounts in the Fund may not be used for the administrative 
        expenses of any Federal agency, including the Department of the 
        Treasury, the National Institutes of Health, and the National 
        Cancer Institute.
    (f) Contributions Made in Connection With Individual Federal Income 
Tax Returns.--The Secretary of the Treasury shall ensure that each 
individual Federal income tax return form includes a line that allows 
the taxpayer to designate any overpayment (including any overpayment 
attributable to any payment made with such return) as a contribution to 
the One Lunch 4 Cure National Pediatric Cancer Contribution Fund and 
shall ensure that any amount so designated is transferred to such Fund.
    (g) Budgetary Effects.--
            (1) Statutory paygo scorecards.--The budgetary effects of 
        this section shall not be entered on either PAYGO scorecard 
        maintained pursuant to section 4(d) of the Statutory Pay-As-
        You-Go Act of 2010 (Public Law 111-139; 2 U.S.C. 933(d)).
            (2) Senate paygo scorecards.--The budgetary effects of this 
        section shall not be entered on any PAYGO scorecard maintained 
        for purposes of section 4106 of H. Con. Res. 71 (115th 
        Congress).

SEC. 9. RULE OF CONSTRUCTION.

    Nothing in this Act shall reduce or replace existing pediatric 
cancer programs.

SEC. 10. FUNDING.

    (a) Appropriation.--There is appropriated to carry out this Act, 
not including section 8, $2,000,000,000 for the period of fiscal years 
2027 through 2036.
    (b) Protected Allocation.--The amount appropriated by subsection 
(a) shall not be reallocated from pediatric research to adult cancer 
programs.
                                 <all>
Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote